At MedTech Pitch Partners, we craft exit strategies that turn your MedTech innovation into a rewarding payoff, whether through acquisition or licensing. Based in Scottsdale’s MedTech Incubator, we leverage deep expertise in orthopedics, spine, and healthcare IT to maximize your value. We analyze your IP, clinical outcomes, and market potential, positioning your startup as a prime target for buyers like Stryker or healthcare IT firms.

Our approach optimizes your valuation and terms with precision. We tie financial projections and milestones—like FDA clearance—to a defensible asking price, advising on deal structures (cash, stock, or earn-outs) that fit your goals and market trends. We also engage potential buyers through our network, fostering competition to secure the best outcome.

Timing and readiness are key. We pinpoint the ideal exit window—such as peak M&A activity in spine surgery—while preparing thorough due diligence materials, from cap tables to regulatory files. This ensures smooth negotiations, preserves shareholder equity, and delivers a strong exit in the surgical suite sector.